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ious centers.21 Failure of the box lesion and incisional AFL
were found more frequently in this series.21 Atypical electro-
cardiographic appearance of flutter after the maze procedure
was common, making rhythm diagnosis difficult from sur-
face recordings, as discussed in another article.22 EP map-
ping confirmed the mitral annulus and cavotricuspid
isthmus as common sites of failure, and ablation success-
fully treated these rhythms.22 We suggest that others also
try to obtain late catheter ablation to correct remaining AF
and add to the paucity of late data regarding failure mode.
Also, successful ablation was achieved in 67% of our
patients.
This report is limited in that only those patients who
returned for mapping provided information; most asymp-
tomatic patients would not return for mapping. Also, the
PVI group was older, and other mechanisms (eg, failure of
the PVI lesions) might be underreported. Conceivably,
patients with asymptomatic recurrences who did not seek
ablation might have had different mechanisms, although
there is no reason to suspect that. Althoughmost of the group
was followed prospectively, for 18 months before 2006,
management of the patients was less directed, and follow-
up was retrospective. This would not affect the EP findings,
however.
In summary, late mapping and ablation found a high rate
of failure with HIFU for patients with AF undergoing stand-
alone operations. Isolated left-sided surgical procedures
allow for right-sided sources of AF that might cause symp-
tomatic failure. We now perform more biatrial procedures,
especially if the right atrium needs to be opened anyway
(eg, tricuspid surgery). Mitral isthmus failure and failure
of PVI or the box lesion can occur, and care must be taken
to create complete transmural lesions. Because of a low
need for late ablation and the high success rate of the classic
maze procedure, it is still the gold standard procedure for
symptomatic patients.
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Dr Chuen-Neng Lee (Singapore, Singapore). Where does AF
surgery fail? I think this is a complex and difficult subject, and
Dr McCarthy should be complimented for providing information
on this subject. This study has several problems. There is obvious
inherent patient selection bias with significantly differing subsets,
each of which have different mechanisms for AF. The study design
is complicated, attempting to delineate 5 techniques (3 different
surgical approaches), each with a modality of having inherent
modes of failure, different ability to deliver transmurality, inade-
quate design of the instrument, and varying ability to produce
lesion sets.
The study is further complicated by having 4 ways to compare
outcomes, and the study was switched halfway from a retrospective
study to a prospective study. It is unclear what percentage of the pa-
tients actively returned for mapping in each category, although it
seemed to be a very small minority. No mention was made of the
results of cryoablation versus RF ablation.ery c April 2010
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failure, but at the end of the day, the choice of AF techniques
remained a maze procedure. I think further work will need to be
focused on this mechanism.
I have just one question for DrMcCarthy.What are the statistical
power and a numbers needed for such a study with varying subsets
of patients? Did we achieve this with the 408 patients we have in
this series?
Thank you.
DrMcCarthy. Thanks, Dr Lee. First, it is a complex study in that
it reflects the reality of the complexity of the patients we face every
day. For instance, a simple study would be to do a classic maze pro-
cedure on all comers, but of course, that is not realistic because you
are not going to do that in an 82-year-old patient undergoing a redo
double-valve operation.Another overly simple studywould be to do
PVI in all patients, but that would not reflect the needs of very symp-
tomatic patients who failed catheter ablation and were referred
for surgical intervention. Therefore this study reflects what cardiac
surgeons see every day and how can they best treat these patients.
We did transition from a retrospective to a prospective study 16
months after the beginning of the study, but the AF nurses then
went back and aggressively followed up with all the patients
from before to put them into the protocol. Therefore they are not
‘‘lost,’’ as many patients are in a retrospective study.
The statistical question I did not totally understand about how
many patients we would need in different groups. I was not clear
about that question. Could you repeat that?
Dr Lee. To differentiate so many different modalities of treat-
ment, do you have enough numbers to tell the difference statisti-
cally?
Dr McCarthy. No, we did not ask the statistician, for instance,
how we would be able to do that in terms of determining howmany
patients in each group would need to be put into different groups to
randomize that. We just asked him to analyze the patient group that
we had actually studied.
Dr Niv Ad (Falls Church, Va). Pat, I enjoyed your presentation,
and I think it is a very important one. Because you were one of the
first adopters of HIFU, and obviously the technology failed, do you
have any conclusions regarding the next technology coming to your
hospital? Will it change anything in the way you assess technology
and adopt it?
Dr McCarthy. Good question. We were disappointed with
HIFU. I know they are still working on it to try to tweak it and
make it better. I still, as discussed yesterday, am a big believer in
bipolar RF and also cryoablation. Therefore the vast majority of
patients had those technologies applied to create the lesion sets,
as well as the cut-and-sew procedure. At this point, people have
tried things like lasers, but I believe that company is out of business,
and we have combined endocardial and epicardial approaches in
the laboratory that perhaps would be available for truly minimally
invasive procedures as sort of a hybrid approach, but all of that is
still in the design phase. We are still waiting for the perfect technol-
ogy that we will be able to use to do truly port-access, minimally
invasive AF surgery.
Dr Jason Sperling (Ridgewood, NJ). Thanks, Dr McCarthy.
Great talk. I have 2 questions. One is technical and relates to the
failures in the LA isthmus. Specifically, I was interested to know
what your technique was in the isthmus. Did you cut down ontoThe Journal of Thoracic and Cathe coronary sinus itself and cryoablate the coronary sinus, or
was this just cryoablation over the region endocardially? The sec-
ond question is related to the HIFU failures. To your recollection,
is there any chance that all or a lot of those ablation line failures
were in the dome of the left atrium given that the technique went
through the transverse sinus as opposed to being directly on the
dome? Perhaps that was a modality of failure?
Dr McCarthy. The technique to the MV annulus for the classic
maze procedure was cut-and-sew to the MV annulus, but we also
would apply cryoablation over it. For the others, we did not actually
take a knife and open to theMV annulus but used cryoablation with
a 5-mm Frigitronics probe, and in the last approximately 80 pa-
tients, we have been using 2 Frigitronics probes next to each other
to create a very wide line after we found some failures of the MV
annulus lesion.
The failures of HIFU varied. There were some in which there
was no evidence at all that there had been a line created. In others
where there was evidence of block, it appeared that the break-
through was most commonly near the left upper pulmonary vein.
Because the HIFU creates a round cinch but the atria is actually
more oblong, we thought that perhaps it would not have been
very good contact with the atrial wall in the round cinch, perhaps
on the part farthest away from the surgeon, and you would not
have been able to see that very well.
Dr Thorsten Hanke (Lu¨beck, Germany). In the HIFU group
most of the patients seemed to have a fairly high grade of mitral
regurgitation. Were those also the patients with an enlarged left
atrium, so that maybe that is why they had a high failure rate? In
the operating room did you check for conduction block? Maybe
those patients could have been selected before.
Dr McCarthy. We go into the HIFU group to a greater extent
in the manuscript. The majority of those patients actually under-
went stand-alone procedures. Of the patients who did have MV
surgery, they were typically myxomatous patients with a high
grade of mitral regurgitation, and they did have a more dilated
left atrium. However, most patients undergoing HIFU were
actually patients undergoing stand-alone procedures with mild
LA enlargement.
We did check for conduction block in the operating room in the
patients undergoing HIFU from the right-sided pulmonary veins,
but we were doing minimally invasive, very small incisions, lower
sternotomy, and we could not get access to the left-sided pulmonary
veins and check conduction block at that point.
Dr Sacha Salzberg (Zurich, Switzerland). Dr McCarthy, I saw
that in your PVI group there were 28% of patients who had either
persistent or permanent AF. Was that because these patients were
too high risk to undergo a long procedure; is it a selection bias?
Because in starting an AF program we often get comments that
this 85-year-old man who needs an AVR and has persistent AF,
well, let’s try and decrease the clamp time and get out as quickly
as possible. I wonder whether you could comment on that.
Dr McCarthy. The PVI group had a relatively small number of
patients, and PVI was used for patients who were older, undergoing
operations in whom we were not otherwise opening the left atrium.
Therefore that would typically be that older patient population with
AVR or CAB. Occasionally, we would also use it in that group be-
cause they had only paroxysmal AF. Therefore there was selection
bias. That was the technique we chose for that group.rdiovascular Surgery c Volume 139, Number 4 867
